Phase 3 Trial

2 trends tracked about this subject — the full history, oldest to newest below.

↓ Cooling Business

MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial

MoonLake Immunotherapeutics reports that its nanobody drug, sonelokimab, successfully met all clinical endpoints in a Phase 3 trial for psoriatic arthritis.

5 sources 5 articles v 3 2h ago

◼ Archived Business 🔮 fades

Compass says depression drug has long-lasting benefits

Compass Pathways' psilocybin depression therapy shows six‑month durability, sparking market optimism.

5 sources 5 articles v 3 33d ago